Anterior chamber, scleral-fixated IOLs yield similar long-term outcomes
Click Here to Manage Email Alerts
Primary anterior chamber IOL implantation and secondary scleral-fixated IOL implantation after complicated cataract surgery in eyes with inadequate capsular support yielded comparable long-term visual outcomes and complication rates, according to a study.
The retrospective study included 89 eyes implanted with a primary anterior chamber IOL (ACIOL) and 74 eyes implanted with a secondary scleral-fixated IOL. Mean follow-up was 64.1 months.
Eyes in the ACIOL group received a single-piece, four-point fixation, open-loop polymethyl methacrylate (PMMA) flexible lens, either the Pharmacia 351C (Pharmacia International) or the S112UV (Bausch + Lomb). Eyes in the secondary scleral-fixated IOL group received a single-piece PMMA IOL with eyelets (MCZ70BD, Alcon).
Mean postoperative BCVA was 0.32 in the primary ACIOL group and 0.34 in the secondary scleral-fixated IOL group at 1 year. The between-group difference was statistically insignificant.
Mean latest BCVA was 0.68 in the primary ACIOL group and 0.61 in the secondary scleral-fixated IOL group. The difference was insignificant.
Both groups had a similar proportion of eyes with BCVA of 20/40 or better at 1 year and final follow-up.
Early postoperative complications within 1 month occurred in 62 of 89 eyes (69.7%) in the primary ACIOL group and in 29 of 74 eyes in the secondary IOL group (39.7%). The between-group difference was statistically significant (P < .001). However, both groups had the same rate of late postoperative complications after 1 month.
“Primary ACIOL implantation allows immediate aphakic correction without prolonging the complicated operation extensively. … On the other hand, secondary scleral-fixated IOL implantation allows better surgical planning in a more controlled situation,” the study authors wrote.
Disclosure: The study authors report no relevant financial disclosures.